Proceedings of the National Academy of Sciences · 1992 · 224 citations · 22 references
MedicineGeneticsMolecular GeneticsCancer GeneticsCytogeneticsMolecular OncologyCancer CytogeneticsOncogene ActivationOncogene AmplificationOncogenic Fusion GenesProto-oncogene ActivationThyroid CancerPapillary Thyroid Carcinoma PathologyParacentric InversionsRet Fusion GenesRet Proto-oncogene AlterationsThyroid Cancer GeneticsTyrosine Kinase Receptors
RET/PTC is a transforming sequence created by the fusion of the tyrosine kinase domain of the RET protooncogene with the 5' end of the locus D10S170 designated by probe H4 and is frequently found activated in human papillary thyroid carcinomas. RET and D10S170 have been mapped to contiguous regions of the long arm of chromosome 10: q11.2 and q21, respectively. To identify the mechanism leading to the generation of the oncogenic sequence RET/PTC, a combined cytogenetic and molecular analysis of several cases of papillary thyroid carcinomas was done. In four cases the results indicated that these tumors had RET/PTC activation and a paracentric inversion of the long arm of chromosome 10, inv(10)(q11.2q21), with breakpoints coincident with the regions where RET and D10S170 are located. Therefore, a chromosome 10q inversion provides the structural basis for the D10S170-RET fusion that forms the hybrid transforming sequence RET/PTC.
22
PCR protocols — A guide to methods and applications
U.G. · Trends in Biochemical Sciences · 1990 · 11.8K citations
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
David M. Hockenbery, Gabriel Núñez, Curt Milliman et al. · Nature · 1990 · 3.8K citations